Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02981342
Title A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

pancreatic ductal adenocarcinoma

Therapies

Capecitabine

Abemaciclib

Gemcitabine

Abemaciclib + LY3023414

Abemaciclib + Galunisertib

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | BEL


No variant requirements are available.